Pw Medtech Group Ltd. logo

Pw Medtech Group Ltd. (1358)

Market Closed
13 Aug, 08:00
HKEX HKEX
0. 92
HKD
-0.01
-0.5435%
HKD
1.54B Market Cap
- P/E Ratio
0.18% Div Yield
1.19M Volume
- Eps
0.92 HKD
Previous Close
Add Transaction
Day Range
0.89 0.92
Year Range
0.89 1.63
Want to track 1358 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1358 closed today lower at 0.92 HKD, a decrease of -0.5435% from yesterday's close, completing a monthly decrease of -16.055% or -0.17 HKD. Over the past 12 months, 1358 stock lost -27.381%.
1358 pays dividends to its shareholders, with the most recent payment made on Jul 31, 2026. The next estimated payment will be in In 5 months on Jan 31, 2027 for a total of 0.02 HKD.
The last earnings report, released on Jun 13, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

1358 Chart

People also search for

Homeland Interactive Technology Ltd.
1.24 HKD
0%
Haosen Fintech Group Ltd.
2.35 HKD
0%
China Aerospace International Holdings Limited
0.51 HKD
+1%
Be Friends Holding Ltd.
0.84 HKD
+5%
Ruihe Data Technology Holdings Limited
2.33 HKD
+1.3072%

Pw Medtech Group Ltd. (1358) FAQ

What is the stock price today?

The current price is 0.92 HKD.

On which exchange is it traded?

Pw Medtech Group Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 1358.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.18%.

What is its market cap?

As of today, the market cap is 1.54B.

Has Pw Medtech Group Ltd. ever had a stock split?

No, there has never been a stock split.

Pw Medtech Group Ltd. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Ms. Yue'e Zhang CEO
HKEX Exchange
G7306W108 CUSIP
China Country
1,302 Employees
3 Nov 2025 Last Dividend
- Last Split
- IPO Date

Overview

PW Medtech Group Limited operates as a leading medical device company with its operations primarily based in the People's Republic of China. The company, initially known as Pyholding Limited, has carved its niche in the medical device industry since its establishment in 1997. As an investment holding entity, PW Medtech focuses on the development, manufacturing, and distribution of a wide range of medical devices and products aimed at improving healthcare standards and patient care. Headquartered in Beijing, the company has successfully embedded itself as a key player in China's thriving medical device sector.

Products and Services

PW Medtech Group Limited offers an extensive portfolio of medical devices and products across various healthcare sectors. These include:

  • Infusion Sets: The company specializes in the production and sale of various infusion sets, catering to the needs of healthcare providers. Their range includes non-PVC-based infusion sets designed for patients who require biocompatible and safer infusion solutions, precision filter infusion sets that ensure the delivery of solutions free from particulate matter, light-resistant infusion sets engineered to protect light-sensitive medications during infusion, and intravenous cannula products along with insulin needles and pens, further supporting medical professionals in providing optimal patient care.
  • Hemodialysis and Blood Purification Medical Devices: PW Medtech has developed a strong foothold in the renal care market with its comprehensive range of hemodialysis and blood purification devices. This includes high flux hemodialyzers that are designed for efficient removal of toxins from the blood, low flux hemodialyzers suited for patients requiring gentler dialysis, hemodiafilters that combine diffusive and convective solute removal in hemodialysis, and hemoperfutors, which are used in blood purification therapies to remove toxins.
  • Animal-Derived Regenerative Medical Biomaterials and Human Tissue Repair Products: Expanding its portfolio into the regenerative medicine space, the company offers biomaterials derived from animal sources and alternative products for human tissue repair. These innovative products are intended to facilitate the natural healing process, offering solutions for tissue regeneration and repair, underscoring PW Medtech's commitment to advancing healthcare through innovation.

Contact Information

Address: Building 1
Phone: -